Zydus Life Science

984.65
+10.10
(1.04%)
Market Cap (₹ Cr.)
₹98,063
52 Week High
1,324.30
Book Value
₹197
52 Week Low
630.00
PE Ratio
22.93
PB Ratio
4.49
PE for Sector
41.08
PB for Sector
4.17
ROE
17.34 %
ROCE
27.38 %
Dividend Yield
0.31 %
EPS
₹41.43
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
13.82 %
Net Income Growth
91.39 %
Cash Flow Change
20.05 %
ROE
70.50 %
ROCE
58.54 %
EBITDA Margin (Avg.)
23.08 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
1,469
1,933
1,998
1,788
1,488
967
812
810
1,225
1,095
1,806
1,617
1,501
1,611
2,054
1,725
1,714
1,371
1,977
1,761
2,225
1,816
2,118
1,944
1,992
2,153
2,078
1,856
2,031
2,033
2,371
2,149
2,831
3,038
2,694
2,478
3,694
4,267
2,947
Expenses
991
1,187
1,163
1,137
968
740
694
716
759
844
1,088
1,149
1,082
1,121
1,135
1,219
1,262
1,161
1,156
1,360
1,345
1,207
1,429
1,608
1,415
1,506
1,844
1,472
1,519
1,437
1,583
1,554
2,011
1,815
1,510
1,672
1,772
1,787
1,678
EBITDA
478
746
835
650
520
227
118
94
466
250
717
467
419
490
919
506
452
210
821
402
881
609
688
336
577
647
234
385
511
596
788
595
820
1,223
1,184
806
1,922
2,480
1,269
Operating Profit %
26 %
32 %
34 %
28 %
28 %
14 %
3 %
-0 %
-0 %
15 %
36 %
24 %
22 %
21 %
28 %
24 %
21 %
9 %
20 %
16 %
21 %
29 %
27 %
12 %
27 %
26 %
4 %
14 %
21 %
22 %
29 %
19 %
18 %
37 %
26 %
25 %
44 %
56 %
33 %
Depreciation
56
52
55
55
60
59
69
68
55
66
70
78
79
84
88
90
88
90
105
110
112
111
112
113
115
117
119
120
123
123
124
122
120
121
125
128
131
131
134
Interest
14
6
8
6
7
6
6
4
-4
12
24
3
25
38
41
-16
25
26
83
48
63
20
15
16
21
44
24
25
42
41
64
89
85
90
91
104
106
115
96
Profit Before Tax
409
688
773
589
453
162
43
23
415
172
623
387
315
368
791
432
338
94
633
243
706
478
561
207
442
486
91
240
347
432
600
385
615
1,013
968
574
1,685
2,234
1,039
Tax
62
123
139
106
87
32
0
1
27
36
130
82
71
63
136
75
70
16
85
47
19
84
100
64
56
85
73
25
78
101
145
86
130
236
172
119
408
532
249
Net Profit
347
565
635
484
354
130
38
22
471
91
450
306
243
310
667
363
262
79
554
214
619
398
473
140
465
400
14
197
247
332
451
256
491
781
805
450
1,405
1,701
790
EPS in ₹
16.95
27.59
6.20
4.73
3.46
1.27
0.37
0.21
4.60
0.89
4.39
2.99
2.36
3.03
6.51
3.55
2.56
0.77
5.40
2.09
6.05
3.89
4.62
1.37
4.54
3.91
0.14
1.92
2.41
3.24
4.45
2.53
4.85
7.71
7.96
4.45
13.89
16.90
7.85

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
7,337
8,923
11,047
12,164
13,671
16,552
18,464
17,740
20,564
24,085
Fixed Assets
1,768
2,155
2,352
2,680
3,933
4,109
4,112
4,336
4,184
4,369
Current Assets
2,697
2,923
2,139
3,557
4,262
4,793
6,032
6,837
7,158
7,911
Capital Work in Progress
367
297
678
659
675
553
571
384
739
634
Investments
458
2,318
3,924
3,618
4,195
6,404
6,471
5,118
4,879
7,283
Other Assets
4,744
4,154
4,093
5,206
4,869
5,486
7,311
7,902
10,761
11,799
Total Liabilities
7,337
8,923
11,047
12,164
13,671
16,552
18,464
17,740
20,564
24,085
Current Liabilities
2,020
1,922
3,014
2,791
2,806
3,449
4,821
4,028
2,790
2,541
Non Current Liabilities
792
725
1,415
1,628
2,296
1,842
898
472
4,134
5,827
Total Equity
4,525
6,276
6,618
7,746
8,569
11,260
12,745
13,241
13,639
15,717
Reserve & Surplus
4,423
6,174
6,516
7,643
8,467
11,158
12,642
13,138
13,538
15,616
Share Capital
102
102
102
102
102
102
102
102
101
101

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
120
14
-247
167
-67
269
-231
149
-54
-132
Investing Activities
-577
-1,016
-2,480
28
-713
55
-2,714
586
-1,959
-1,831
Operating Activities
1,084
1,954
867
288
581
1,181
2,227
1,272
1,078
1,999
Financing Activities
-387
-923
1,366
-149
65
-967
255
-1,710
827
-301

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
74.88 %
74.88 %
74.88 %
74.88 %
74.88 %
74.88 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.72 %
5.59 %
7.52 %
DIIs
11.11 %
10.43 %
11.22 %
11.78 %
12.78 %
11.92 %
12.94 %
13.69 %
13.60 %
13.23 %
13.09 %
12.79 %
12.63 %
12.64 %
10.65 %
Government
0.19 %
0.07 %
0.07 %
0.07 %
0.08 %
0.08 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.16 %
7.31 %
7.38 %
7.40 %
7.81 %
8.02 %
7.60 %
7.04 %
6.42 %
5.97 %
5.67 %
5.60 %
5.29 %
5.37 %
5.48 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,796.80 4,33,931.70 38.70 49,887.20 12.06 9,648 27.34 51.02
1,541.45 1,21,755.80 26.38 26,520.70 14.17 4,155 12.95 47.09
2,584.00 1,04,826.50 49.54 10,615.60 19.57 1,942 28.89 52.27
1,220.65 1,01,936.60 19.09 28,905.40 12.36 5,578 -9.47 42.97
984.00 98,062.50 22.93 19,831.50 13.82 3,831 14.57 48.47
2,081.00 94,399.90 35.95 20,141.50 19.94 1,936 73.53 47.09
1,247.85 72,876.10 20.17 29,559.20 17.55 3,169 8.66 35.95
5,639.35 68,065.40 31.30 12,978.40 9.84 1,812 14.16 50.35
375.25 45,064.50 32.35 15,621.20 35.25 1,298 -84.31 68.22
1,556.70 43,670.00 - 12,653.10 6.58 -1,831 675.49 44.51

Corporate Action

Technical Indicators

RSI(14)
Neutral
48.47
ATR(14)
Less Volatile
20.98
STOCH(9,6)
Neutral
57.21
STOCH RSI(14)
Overbought
88.10
MACD(12,26)
Bullish
4.79
ADX(14)
Strong Trend
49.66
UO(9)
Bearish
51.82
ROC(12)
Uptrend And Accelerating
2.61
WillR(14)
Neutral
-27.11